Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2020-216265
PubMed Identifier: 34556554
Publication URI: http://europepmc.org/abstract/MED/34556554
Type: Journal Article/Review
Volume: 77
Parent Publication: Thorax
Issue: 9
ISSN: 0040-6376